11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial

Treatment options for idiopathic intracranial hypertension are limited. The enzyme 11β-hydroxysteroid dehydrogenase type 1 has been implicated in regulating cerebrospinal fluid secretion, and its activity is associated with alterations in intracranial pressure in idiopathic intracranial hypertension...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Brain Commun
Päätekijät: Markey, Keira, Mitchell, James, Botfield, Hannah, Ottridge, Ryan S, Matthews, Tim, Krishnan, Anita, Woolley, Rebecca, Westgate, Connar, Yiangou, Andreas, Alimajstorovic, Zerin, Shah, Pushkar, Rick, Caroline, Ives, Natalie, Taylor, Angela E, Gilligan, Lorna C, Jenkinson, Carl, Arlt, Wiebke, Scotton, William, Fairclough, Rebecca J, Singhal, Rishi, Stewart, Paul M, Tomlinson, Jeremy W, Lavery, Gareth G, Mollan, Susan P, Sinclair, Alexandra J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425517/
https://ncbi.nlm.nih.gov/pubmed/32954315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcz050
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia